ORMEAU CLINICAL TRIALS LIMITED
Significant control: Damien Mcnally (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ormeau Clinical Trials Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Ormeau Clinical Trials Limited sell?
Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ORMEAU CLINICAL TRIALS LIMITED is an active private limited company (company number NI642434) incorporated on 29 November 2016, registered in Belfast. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 31 March 2025, showing net assets of £776k and cash of £118k, with 20 employees on average. Net assets rose 8% on the prior period (£717k).
By net assets it sits in the top quarter of 629 comparable companies in Belfast (median £3,011, upper quartile £34k).
Ownership and control
- Dr Damien Mcnally
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 29 November 20169 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 13 December 2026in 50 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £776k | £118k | £464k | — | — | — | 20 |
| 31 March 2024 | £717k | £609k | £312k | — | — | — | 11 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £776,141 at 31 March 2025
- Cash at bank of £50,000 or moreCash £118,055
- Incorporated five or more years agoIncorporated 29 November 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 68 days
- Confirmation statement duein 50 days
- Accounts period endNet assets £776k · small accounts
- Accounts period endNet assets £717k · small accounts
- Incorporated
Similar companies in Belfast
- GIBSONS HEALTHCARE LTDColeraine · inc. Dec 2016
- BOPHARM LTDLimavady · inc. Dec 2016
- BALLYQUIN INVESTMENTS LTDColeraine · inc. Jan 2017
- TENZA HEALTHCARE LIMITEDBallymena · inc. Jan 2017
- TEN TO ZEN LIMITEDBelfast · inc. Jan 2017
- EMA WELLBEING LTDBelfast · inc. Feb 2017
All companies incorporated on 29 November 2016 · in Nov 2016.
Reminders for ORMEAU CLINICAL TRIALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.